Quidel Triage Cardiac Notice D'utilisation page 24

Laure, C., Calzolari, C., Bertinchant, J-P., Leclercq, F., Grolleau, R., and Pau, B. Cardiac
Specific Immunoenzymometric Assay for Troponin I in the Early Phase of Acute Myocardial
Infarction. Clin. Chem. 39: 972-979, 1993.
Adams, J.E., Schechtman, K.D., Landt, Y., Ladenson, J.H., and Jaffe, A.S. Comparable
Detection of Acute Myocardial Infarction by Creatine Kinase MB Isoenzyme and Cardiac
Troponin I. Clin. Chem. 40: 1291-1295, 1994.
Adams, J.E., Sicard, G.A., Allen, B.T., Bridwell, K.H., Lenke, L.G., Davila-Roman, V.G., Bodor,
G.S., Ladenson, L.H., and Jaffe, A.S. Diagnosis of Perioperative Myocardial Infarction with
Measurement of Cardiac Troponin I. N. Eng. J. Med. 330: 670-674, 1994.
Brogan, G.X., Hollander, J.E., McCuskey, C.F., Thode, Jr., H.C., Sama, A., Bock, J.L., and
the Biochemical Markers for Acute Myocardial Ischemia Study Group. Evaluation of a New
Assay for Cardiac Troponin I vs Creatine Kinase-MB for the Diagnosis of Acute Myocardial
Infarction. Acad. Emerg. Med. 4: 6-12, 1997.
Davis, C.P., Barnett, K., Torre P., and Wacasey, K. Serial Myoglobin Levels for Patients with
Possible Myocardial Infarction. Acad. Emerg. Med. 3: 590-597, 1996.
Gibler, W.B., Gibler, C.D., Weinshenker, E., Abbotsmith, C., Hedges, J.R., Barsan, W.G.,
Sperling, M., Chen, I-W., Embry, S., and Kereiakes, D. Myoglobin as an Indicator of Acute
Myocardial Infarction. Ann. Emerg. Med. 16: 851-856, 1987.
Tucker, J.F., Collins, R.A., Anderson, A.J., Hess, M., Farley, I.M., Hegemann, D.A., Harkins
H.J., and Zwicke, D. Value of Serial Myoglobin Levels in the Early Diagnosis of Patients
Admitted for Acute Myocardial Infarction. Ann. Emerg. Med. 24: 704-708, 1994.
Adams, J.E., Bodor, G., D-Roman, V.G., Delmez, J.A., Apple, F.S., Ladenson J.H., and Jaffe,
A.S. Cardiac Troponin I: A Marker with High Specificity for Cardiac Injury. Circulation 88:
101-106, 1993.
Buechler, K.F., and McPherson, P.H. Novel Methods for the Assay of Troponin I and T and
Complexes of Troponin I and T and Selections of Antibodies for Use in Immunoassays.
International Patent WO 96/33415, 18 April, 1995.
Katrukha, A.G., Bereznikova, A.V., Esakova, T.V., Pettersson, K., Lövgren, T., Severina, M.E.,
Pulkki, K., Vuopio-Pulkki, L.-M., and Gusev, N.B. Troponin I is released in bloodstream of
patients with acute myocardial infarction not in free form but as complex. Clin. Chem. 43:
1379-1385, 1997.
Galvani, M., Ferrini, D., Ghezzi, F., and Ottani, F., Cardiac markers and risk stratification: an
integrated approach. Clin Chim Acta 311: 9-17, 2001
Meyer, T., Binder, L., Graeber, T., Luthe, H., Kreuzer, H., Oellerich, M., Buchwald, A.B.,
Superiority of combined CK-MB and troponin I measurements for the early risk stratification
of unselected patients presenting with acute chest pain. Cardiology 90: 286-294, 1998
de Winter, R.J., Risk stratification with cardiac troponin I in acute coronary syndromes.
J. Am. Coll. Cardiol. 36: 1824-1826, 2000
Newby, L.K., Storrow, A.B., Gibler, W.B., Garvey, J.L., Tucker, J.F., Kaplan, A.L., Schreiber,
D.H., Tuttle, R.H., McNulty, S.E., and Ohman, E.M., Bedside multimarker testing for risk
stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin,
and troponin I (CHECKMATE) study. Circulation 103: 1832-1837, 2
22 Triage Cardiac